TY  - JOUR
AU  - Mallandrich, Mireia
AU  - Fernández-Campos, Francisco
AU  - Clares, Beatriz
AU  - Halbaut, Lyda
AU  - Alonso, Cristina
AU  - Coderch, Luisa
AU  - Garduño-Ramírez, Maria L
AU  - Andrade, Berenice
AU  - Del Pozo, Alfonso
AU  - Lane, Majella E
AU  - Calpena, Ana C
PY  - 2017
DO  - 10.1007/s11095-017-2181-8
UR  - http://hdl.handle.net/10668/11232
T2  - Pharmaceutical research
AB  - In order to obtain dermal vehicles of ketorolac tromethamine (KT) for the local treatment of inflammation and restrict undesirable side effects of systemic levels hydrogels (HGs) of poloxamer and carbomer were developed. KT poloxamer based HG...
LA  - en
KW  - carbomer
KW  - hydrogels
KW  - ketorolac tromethamine
KW  - poloxamer
KW  - transdermal
KW  - Administration, Cutaneous
KW  - Adult
KW  - Animals
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - Biological Availability
KW  - Excipients
KW  - Female
KW  - Humans
KW  - Hydrogels
KW  - Hydrogen-Ion Concentration
KW  - Ketorolac Tromethamine
KW  - Mice
KW  - Middle Aged
KW  - Models, Biological
KW  - Permeability
KW  - Poloxamer
KW  - Porosity
KW  - Skin Absorption
KW  - Tissue Distribution
KW  - Viscosity
KW  - Young Adult
TI  - Developing Transdermal Applications of Ketorolac Tromethamine Entrapped in Stimuli Sensitive Block Copolymer Hydrogels.
TY  - research article
VL  - 34
ER  -